Detalhe da pesquisa
1.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35921449
2.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36709074
3.
Clonal hematopoiesis is not significantly associated with COVID-19 disease severity.
Blood
; 140(14): 1650-1655, 2022 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35839449
4.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
NPJ Vaccines
; 9(1): 67, 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38553525
5.
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
JCI Insight
; 9(7)2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38587079
6.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37075129
7.
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Lancet Infect Dis
; 23(5): 578-588, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36708738
8.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37544326
9.
Gastrointestinal Manifestations in Hospitalized Children With Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry.
Pediatr Infect Dis J
; 41(9): 751-758, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35622434
10.
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Lancet Infect Dis
; 22(8): 1210-1220, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35568049
11.
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
EClinicalMedicine
; 48: 101477, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35783486
12.
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
Nat Med
; 28(2): 383-391, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35115706